A 6-Hour Clinical Evaluation of New Daily-Wear Soft Contact Lenses

September 21, 2020 updated by: CooperVision, Inc.
The purpose of this study is to validate the clinical performance of a new contact lens design when worn over a period of 6 hours compared to nelfilcon A (control).

Study Overview

Status

Completed

Conditions

Detailed Description

The purpose of this study is to validate the clinical performance of a new contact lens design when worn over a period of 6 hours compared to nelfilcon A (control). The primary outcomes of interest are lens fit and lens fit preference.

Study Type

Interventional

Enrollment (Actual)

31

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Indiana
      • Bloomington, Indiana, United States, 47405
        • Clinical Optics Research Lab (CORL) Indiana University School of Optometry, Indiana University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Is at least 18 years of age and has full legal capacity to volunteer
  • Has read, fully understood and signed the information consent letter
  • Currently wears or has previously worn soft contact lenses
  • Has spectacle cylinder ≤1.00D in both eyes.
  • Has spherical contact lens power requirement between -1.00D and -6.00D in both eyes.
  • Has manifest refraction visual acuities (VA) equal to or better than logMAR equivalent of 20/25 in each eye.
  • Has clear corneas and no active ocular disease
  • Is willing and able to follow product usage instructions and maintain the visit schedule.

Exclusion Criteria:

  • Has never worn contact lenses before
  • Has a systemic condition that in the opinion of the investigator may affect a study outcome variable
  • Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable
  • Has any known active ocular disease and/or infection
  • Has a monovision correction
  • Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses
  • Is aphakic
  • Has undergone corneal refractive surgery
  • Is pregnant or lactating, determined by self-report

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NON_RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Test lens
Each subjects will wear a test lens in one eye and the control lens in the other as an unmatched pair, per predetermined randomization schedule (to determine which eye receives test/control lens).
Daily disposable contact lens
Focus Dailies All Day Comfort contact lens (nelfilcon A)
ACTIVE_COMPARATOR: nelfilcon A lens (control)
Each subjects will wear a test lens in one eye and the control lens in the other as an unmatched pair, per predetermined randomization schedule (to determine which eye receives test/control lens).
Daily disposable contact lens
Focus Dailies All Day Comfort contact lens (nelfilcon A)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Horizontal Lens Centration Assessed in Primary Gaze
Time Frame: Baseline
Horizontal Lens Centration assessed in primary gaze was measured in 0.1mm steps. (mm-nasal decentration given +ve value, temporal decentration given -ve value)
Baseline
Horizontal Lens Centration Assessed in Primary Gaze
Time Frame: 6-hour
Horizontal Lens Centration assessed in primary gaze was measured in 0.1mm steps. (mm-nasal decentration given +ve value, temporal decentration given -ve value)
6-hour
Vertical Lens Centration Assessed in Primary Gaze
Time Frame: Baseline
Vertical Lens Centration assessed in primary gaze was measured in 0.1mm steps. (mm-superior decentration given +ve value, inferior decentration given -ve value)
Baseline
Vertical Lens Centration Assessed in Primary Gaze
Time Frame: 6-hours
Vertical Lens Centration assessed in primary gaze was measured in 0.1mm steps. (mm-superior decentration given +ve value, inferior decentration given -ve value)
6-hours
Lens Tightness Assessed by Push-up Test
Time Frame: Baseline
Lens Tightness was assessed by Push-up test 1% steps: (0%=Falls from cornea without lid support, 50%=Optimum, 100%=No movement)
Baseline
Lens Tightness Assessed by Push-up Test
Time Frame: 6-hours
Lens Tightness was assessed by Push-up test 1% steps: (0%=Falls from cornea without lid support, 50%=Optimum, 100%=No movement)
6-hours
Primary Gaze Lag Assessed Observing Lens Movement in Graticule
Time Frame: Baseline
Primary gaze lag was assessed observing lens movement in graticule (0.1mm steps)
Baseline
Primary Gaze Lag Assessed Observing Lens Movement in Graticule
Time Frame: 6 hours
Primary gaze lag was assessed observing lens movement in graticule (0.1mm steps)
6 hours
Horizontal Lens Lag Assessed Observing Lens Movement in Graticule
Time Frame: Baseline
Horizontal lens lag was assessed observing lens movement in graticule (0.1mm steps)
Baseline
Horizontal Lens Lag Assessed Observing Lens Movement in Graticule
Time Frame: 6 hours
Horizontal lens lag was assessed observing lens movement in graticule (0.1mm steps)
6 hours
Overall Lens Fit Acceptance
Time Frame: Baseline
Overall lens fit acceptance based on lens fit alone (scale 0-4 in 0.25 steps: 0=can't be worn, 1=Poor, 2=Fair, 3=Good, 4=Optimum)
Baseline
Overall Lens Fit Acceptance
Time Frame: 6 hours
Overall lens fit acceptance based on lens fit alone (scale 0-4 in 0.25 steps: 0=can't be worn, 1=Poor, 2=Fair, 3=Good, 4=Optimum)
6 hours
Up Gaze Lag Assessed Observing Lens Movement in Graticule
Time Frame: Baseline
Up gaze lag was assessed observing lens movement in graticule (0.1mm steps) (The amount of lens drop in mm that occurs when the eye moves from primary gaze to up gaze).
Baseline
Up Gaze Lag Assessed Observing Lens Movement in Graticule
Time Frame: 6 hours
Up gaze lag was assessed observing lens movement in graticule (0.1mm steps) (The amount of lens drop in mm that occurs when the eye moves from primary gaze to up gaze).
6 hours
Post-blink Movement Assessed by Amount of Lens Movement Immediately After the Blink
Time Frame: Baseline
Post-blink Movement was assessed by amount of movement (to the nearest 0.1mm) immediately after the blink
Baseline
Post-blink Movement Assessed by Amount of Lens Movement Immediately After the Blink
Time Frame: 6 hours
Post-blink Movement was assessed by amount of movement (to the nearest 0.1mm) immediately after the blink
6 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 25, 2017

Primary Completion (ACTUAL)

August 3, 2017

Study Completion (ACTUAL)

August 3, 2017

Study Registration Dates

First Submitted

July 27, 2017

First Submitted That Met QC Criteria

July 27, 2017

First Posted (ACTUAL)

August 1, 2017

Study Record Updates

Last Update Posted (ACTUAL)

October 14, 2020

Last Update Submitted That Met QC Criteria

September 21, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CV-17-46

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia

Clinical Trials on Test Lens

Subscribe